Principal Financial Group’s CorMedix CRMD Stock Holding History

Principal Financial Group’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.5M	Buy	190,941 +11,404	+6%	+$90.1K	﹤0.01%	1883
2026 Q1	$1.22M	Buy	179,537 +52,804	+42%	+$390K	﹤0.01%	1897
2025 Q4	$1.47M	Buy	126,733 +40,296	+47%	+$445K	﹤0.01%	1892
2025 Q3	$1.01M	Buy	+86,437	New	+$1.05M	﹤0.01%	1925
2024 Q3	–	Sell	-10,229	Closed	-$44.3K	–	2267
2024 Q2	$44.3K	Buy	+10,229	New	+$52K	﹤0.01%	2296
2020 Q2	–	Sell	-19,724	Closed	-$71K	–	2328
2020 Q1	$71K	Buy	19,724 +67	+0.3%	+$378	﹤0.01%	2141
2019 Q4	$143K	Sell	19,657 -6,938	-26%	-$42.4K	﹤0.01%	2172
2019 Q3	$170K	Buy	26,595 +188	+0.7%	+$1.58K	﹤0.01%	2155
2019 Q2	$237K	Buy	+26,407	New	+$207K	﹤0.01%	2114

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Principal Financial Group's CRMD Position: Q2 2026 in Review

Principal Financial Group increased its CorMedix (CRMD) stake by 6.4% in Q2 2026, buying an estimated $90.1K and bringing the position to 190,941 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1883.

Principal Financial Group first reported a position in CRMD in Q2 2019 and has held it in 9 quarters since. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Principal Financial Group held 190,941 shares of CorMedix worth $1.5M as of Q2 2026.
Principal Financial Group bought 11,404 CorMedix shares in Q2 2026, an estimated $90.1K.
CorMedix made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1883 holding.
Principal Financial Group first reported a position in CorMedix in Q2 2019 and has held it in 9 quarters since.
193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.